Medtronic disclosed Diabetes unit executive pay packages for 2025 and compensation targets for when they'll lead MiniMed as a ...

Explore MiniMed Group, Inc.'s upcoming IPO, market position in diabetes devices, and key financial risks. Click for this MMED ...

We recap the year's biggest executive hirings, promotions and departures at Medtronic, J&J MedTech, Intuitive and other ...

Medtronic's (NYSE: MDT) diabetes unit, MiniMed Group, filed for a U.S. initial public offering (IPO) on Friday.

Medtronic, a global leader in healthcare technology, today announced the launch of its pioneering Mobile Surgi-skill Lab- a ...

MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.

Digital patient monitoring systems (DPMS) market refer to a broad spectrum of technologies designed to continuously monitor ...

Medtronic plc (MDT) filed a registration statement with the U.S. Securities and Exchange Commission for an initial public offering of its diabetes business, which will operate under the name MiniMed, ...

With the Own It effort, Medtronic is providing a way for those living with diabetes to celebrate ordinary moments made possible with the right technology so they can own every choice.

The Northridge, California-based company had a net loss of $21 million on revenue of $1.5 billion for the six months ended ...

Goldman Sachs, BofA Securities, Citigroup and Morgan Stanley are the ​lead underwriters for the IPO. MiniMed, which has tapped more than 10 underwriters for the offering, will list on the Nasdaq under ...

MiniMed intends to apply to have its common stock listed on the Nasdaq Global Select Market under the symbol MMED. The number of shares to be offered and the price range for the offering have not yet ...